|
1
|
Jin Z, Suen Chun K and Ma D: Perioperative
‘remote’ acute lung injury: Recent update. J Biomed Res.
31:197–212. 2017.PubMed/NCBI
|
|
2
|
Hayes M, Curley G, Ansari B and Laffey JG:
Clinical review: Stem cell therapies for acute lung injury/acute
respiratory distress syndrome - hope or hype? Crit Care.
16:2052012. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Han F, Luo Y, Li Y, Liu Z, Xu D, Jin F and
Li Z: Seawater induces apoptosis in alveolar epithelial cells via
the Fas/FasL-mediated pathway. Respir Physiol Neurobiol. 182:71–80.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Al-Biltagi MA, Abo-Elezz AA, Elshafiey RM,
Suliman GA, Mabrouk MM and Mourad HA: The predictive value of
soluble endothelial selectin plasma levels in children with acute
lung injury. J Crit Care. 32:31–35. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Trajano Lima ET, Sternberg C, Caetano M,
Silva Santos MA, Porto LC, Santos JC, Ribeiro ML, Magalhães CB, Zin
WA, Benjamim CF, et al: Endotoxin-induced acute lung injury is
dependent upon oxidative response. Inhal Toxicol. 23:918–926. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Poljsak B, Suput D and Milisav I:
Achieving the balance between ROS and antioxidants: when to use the
synthetic antioxidants. Oxid Med Cell Longev. 2013:9567922013.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yang C, Jiang J, Yang X, Wang H and Du J:
Stem/progenitor cells in endogenous repairing responses: New
toolbox for the treatment of acute lung injury. J Transl Med.
14:472016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Miller DM, Singh IN, Wang JA and Hall ED:
Administration of the Nrf2-ARE activators sulforaphane and carnosic
acid attenuates 4-hydroxy-2-nonenal-induced mitochondrial
dysfunction ex vivo. Free Radic Biol Med. 57:1–9. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Suniara RK, Jenkinson EJ and Owen JJ: An
essential role for thymic mesenchyme in early T cell development. J
Exp Med. 191:1051–1056. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Shalaby SM, El-Shal AS, Abd-Allah SH,
Selim AO, Selim SA, Gouda ZA, El Motteleb Abd DM, Zanfaly HE,
El-Assar HM and Abdelazim S: Mesenchymal stromal cell injection
protects against oxidative stress in Escherichia
coli-induced acute lung injury in mice. Cytotherapy.
16:764–775. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wilson JG, Liu KD, Zhuo H, Caballero L,
McMillan M, Fang X, Cosgrove K, Vojnik R, Calfee CS, Lee JW, et al:
Mesenchymal stem (stromal) cells for treatment of ARDS: A phase 1
clinical trial. Lancet Respir Med. 3:24–32. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Castro-Manrreza ME and Montesinos JJ:
Immunoregulation by mesenchymal stem cells: Biological aspects and
clinical applications. J Immunol Res. 2015:3949172015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang G, Zou X, Huang Y, Wang F, Miao S,
Liu G, Chen M and Zhu Y: Mesenchymal stromal cell-derived
extracellular vesicles protect against acute kidney injury through
anti-oxidation by enhancing Nrf2/ARE activation in Rats. Kidney
Blood Press Res. 41:119–128. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Pleyer L, Valent P and Greil R:
Mesenchymal stem and progenitor cells in normal and dysplastic
hematopoiesis-masters of survival and clonality? Int J Mol Sci.
17:10092016. View Article : Google Scholar :
|
|
15
|
Lv H, Liu Q, Wen Z, Feng H, Deng X and Ci
X: Xanthohumol ameliorates lipopolysaccharide (LPS)-induced acute
lung injury via induction of AMPK/GSK3β-Nrf2 signal axis. Redox
Biol. 12:311–324. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ware LB and Matthay MA: The acute
respiratory distress syndrome. N Engl J Med. 141:460–470. 2000.
|
|
17
|
Keum YS and Choi BY: Molecular and
chemical regulation of the Keap1-Nrf2 signaling pathway. Molecules.
19:10074–10089. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang Z, Ji C, Wu L, Qiu J, Li Q, Shao Z
and Chen G: Tert-butylhydroquinone alleviates early brain injury
and cognitive dysfunction after experimental subarachnoid
hemorrhage: Role of Keap1/Nrf2/ARE pathway. PLoS One. 9:e976852014.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liu X, Zheng P, Xiaodong G, Guanghui D,
Hongbin CH, Zan ZH, Rongrong H, Xinxin N, Jing SH and Yihua A: A
preliminary evaluation of efficacy and safety of Wharton's jelly
mesenchymal stem cell transplantation in patients with type 2
diabetes mellitus. Stem Cell Research & Therapy. 5:1–9. 2014.
View Article : Google Scholar
|
|
20
|
Jang YO, Kim YJ, Baik SK, Kim MY, Eom YW,
Cho MY, Park HJ, Park SY, Kim BR, Kim JW, et al: Histological
improvement following administration of autologous bone
marrow-derived mesenchymal stem cells for alcoholic cirrhosis: A
pilot study. Liver Int. 34:33–41. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hare JM, Fishman JE, Gerstenblith G,
DiFede Velazquez DL, Zambrano JP, Suncion VY, Tracy M, Ghersin E,
Johnston PV, Brinker JA, Breton E, et al: Comparison of allogeneic
vs autologous bone marrow-derived mesenchymal stem cells delivered
by transendocardial injection in patients with ischemic
cardiomyopathy. JAMA. 308:2369–2379. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ni S, Wang D, Qiu X, Pang L, Song Z and
Guo K: Bone marrow mesenchymal stem cells protect against
bleomycin-induced pulmonary fibrosis in rat by activating Nrf2
signaling. Int J Clin Exp Pathol. 8:7752–7761. 2015.PubMed/NCBI
|
|
23
|
Chang YS, Ahn SY, Yoo HS, Sung SI, Choi
SJ, Oh WI and Park WS: Mesenchymal stem cells for bronchopulmonary
dysplasia: phase 1 dose-escalation clinical trial. J Pediatr.
164:966–972. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Haddad R and Saldanha-Araujo F: Mechanisms
of T-cell immunosuppression by mesenchymal stromal cells: What do
we know so far? BioMed Res Int. 2014:2168062014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Martinet L, Fleury-Cappellesso S,
Gadelorge M, Dietrich G, Bourin P, Fournié JJ and Poupot R: A
regulatory cross-talk between Vγ9Vδ2 T lymphocytes and mesenchymal
stem cells. Eur J Immunol. 39:752–762. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Tasso R, Augello A, Carida' M, Postiglione
F, Tibiletti MG, Bernasconi B, Astigiano S, Fais F, Truini M,
Cancedda R, et al: Development of sarcomas in mice implanted with
mesenchymal stem cells seeded onto bioscaffolds. Carcinogenesis.
30:150–157. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chen W, Huang Y, Han J, Yu L, Li Y, Lu Z,
Li H, Liu Z, Shi C, Duan F, et al: Immunomodulatory effects of
mesenchymal stromal cells-derived exosome. Immunol Res. 64:831–840.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Sabin K and Kikyo N: Microvesicles as
mediators of tissue regeneration. Transl Res. 163:286–295. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Sdrimas K and Kourembanas S: MSC
microvesicles for the treatment of lung disease: a new paradigm for
cell-free therapy. Antioxid Redox Signal. 21:1905–1915. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hashemian SJ, Kouhnavard M and
Nasli-Esfahani E: Mesenchymal stem cells: Rising concerns over
their application in treatment of type one diabetes mellitus. J
Diabetes Res. 2015:6751032015. View Article : Google Scholar : PubMed/NCBI
|
